The role of irreversible pan-HER tyrosine kinase inhibitors in the treatment of HER2-Positive metastatic breast cancer

Human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) is the leading cause of cancer death in women. For patients with HER2-positive MBC, after the failure of multiple lines of treatment, there is no optimal line of therapy. A series of clinical trials confirmed tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zihong, Wang, Jiamei, You, Fengming, Li, Xueke, Xiao, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018043/
https://www.ncbi.nlm.nih.gov/pubmed/36937848
http://dx.doi.org/10.3389/fphar.2023.1142087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018043/
https://www.ncbi.nlm.nih.gov/pubmed/36937848
http://dx.doi.org/10.3389/fphar.2023.1142087

Ejemplares similares